Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib

NCT03097601

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +9 more
Locations: Centre Antoine LACASSAGNE Nice, France

View Trial Details

Completed

Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment

NCT03672240

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: The Icahn School of Medicine at Mt. Sinai New York, United States

Carolina Urologic Research Center Myrtle Beach, South Carolina, United States

View Trial Details

Completed

The New England Bladder Cancer Study

NCT00342875

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma

NCT01649778

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Novartis Investigative Site Phoenix, Arizona, United States

Novartis Investigative Site Orange, California, United States

Novartis Investigative Site Jacksonville, Florida, United States

Novartis Investigative Site Louisville, Kentucky, United States

View all 144 locations

View Trial Details

Completed

Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)

NCT04222374

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Centre Hospitalier Universitaire de Bordeaux Talence, France

View Trial Details

Completed

Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb

NCT04462445

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Not specified

View Trial Details

Completed

Clinical and Histopathologic Characteristics of BAP1 Mutations

NCT01773655

Conditions: Adenocarcinoma, Adenoma, Carcinoma, +40 more
Locations: Memorial Sloan Kettering Westchester Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

NCT03147599

Conditions: Behavior, Behavioral Symptoms, Bladder Cancer, +22 more
Locations: Urology and Nephrology Center Al Mansurah, Aldakahlia, Egypt

View Trial Details

Completed

Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer

NCT00003553

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: NIH - Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Follow-Up Study of Kidney Cancer Patients

NCT00656955

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +9 more
Locations: Dept of Cancer Epidemioology Genetics, Brno, CZ Brno, Czechia

Olomouc University Olomouc, Czechia

National Institute of Occupational Medicine, Lodz, Poland Lodz, Poland

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions